Percutaneous collagen induction is the formal name for microneedling, and it describes the mechanism more honestly than the marketing name does. Fine needles create controlled micro-injuries through the epidermis into the dermis. The dermis responds by repairing itself, and that repair produces new collagen and elastin.
Key Facts
- 0.5–3.5 mm — the needle-depth range across published microneedling devices
- 1.5–2.0 mm — depths generally cited for routine treatment of acne and other scars
- 0.5–1.0 mm — depths typically cited for ageing skin and fine wrinkles
- Under 0.15 mm — needle length on home-care dermarollers, used for topical delivery rather than dermal remodelling
- 192 microneedles — 24 circular arrays of 8 needles in one documented roller configuration
- Non-ablative — the epidermis is largely preserved, which is why dyspigmentation risk is lower than with ablative resurfacing
- TGF, PDGF and CTAP — growth factors released from platelets and neutrophils after micro-injury
- Collagen, elastin and glycosaminoglycans — the three matrix components the healing cascade produces
Why depth is the whole conversation
Published guidance separates depth by indication rather than by preference. Needle lengths of roughly 1.5 to 2.0 mm are generally used for the routine treatment of acne and other scars, while 0.5 mm or 1.0 mm is more typical for ageing skin and wrinkles. The reason is anatomical: scar architecture sits deeper than the fine surface changes of photoageing.
The same logic explains why home-care devices are limited. Home dermarollers use needles under 0.15 mm, which is designed for transdermal delivery of topical substances rather than for dermal remodelling. That is not a weaker version of the clinic treatment. It is a different treatment with a different purpose.
A needle that stops in the epidermis cannot remodel the dermis. Depth is not a comfort setting.
What actually happens after the needle
Once micro-incisions are made, inflammatory mediators drive a three-stage healing process. Transforming growth factor, platelet-derived growth factor and connective tissue activating protein are released from surrounding platelets and neutrophils. These contribute to the production of collagen, elastin and glycosaminoglycans — the components of the extracellular matrix rather than collagen alone.
Neovascularisation follows, improving blood supply to the treated area and supporting the repair. This is why the visible change is gradual: the result is the tissue the body builds over the following weeks, not the injury itself.
Why the epidermis being preserved matters
Microneedling is non-ablative. The epidermis remains relatively intact, which limits adverse events and reduces the risk of dyspigmentation compared with ablative approaches such as CO2 laser resurfacing. In a population spanning Fitzpatrick III to V, where post-inflammatory hyperpigmentation is a genuine concern, that distinction carries real clinical weight.
It is also why microneedling is frequently discussed for melasma and photodamage, where aggressive thermal resurfacing can worsen the presenting problem.
Multiple passes, not one pass deeper
One documented limitation of microneedling is the need for several passes at different needle depths to treat the full depth of the dermis. This matters when comparing protocols: a single pass at maximum depth is not equivalent to a planned sequence across depths, and a clinic that treats every area at one fixed setting is not adjusting for the anatomy in front of it.
What microneedling does not do
It does not lift. Structural descent at the SMAS layer is a different problem addressed by focused ultrasound at a different depth. It does not replace lost volume. And where a scar is tethered from beneath, resurfacing the surface repeatedly will not release the tether — that is a mechanical problem requiring subcision, discussed on our acne scar page.
Where added thermal remodelling is appropriate, radiofrequency can be delivered through the needles themselves. That is a related but distinct treatment, covered in our guide to RF microneedling.
Where microneedling sits against other collagen-stimulating options
Several treatments converge on the same downstream target — the fibroblast — through different routes. Microneedling reaches it mechanically. Radiofrequency reaches it thermally. Injectable biostimulators reach it through biological signalling. None of these is a stronger version of the others; they are different means to a shared end, and the appropriate route depends on what else is present in the skin.
Microcoring is a more recent variant worth knowing about, using hollow needles to remove microscopic cores of tissue rather than simply creating channels. It combines collagen stimulation with a small amount of tissue removal, which addresses laxity in a way conventional microneedling does not. It is a distinct procedure, not an upgrade path.
Course length and why results are assessed late
The healing cascade runs over weeks, and the collagen laid down initially is remodelled toward a denser, more organised form over the months that follow. This is why a single session is rarely the plan and why outcomes are reviewed at intervals rather than immediately after treatment. It also explains why treatments are spaced rather than stacked closely together — the tissue needs the interval to complete a cycle before the next injury is introduced.
Published studies on atrophic acne scarring have compared different penetration depths directly in split-face designs, treating one side at one depth and the other at another across a course of sessions at fixed intervals. That study design exists precisely because depth and interval are the variables that change the outcome.
Combining microneedling with topical delivery
One documented use of the micro-channels is improved penetration of topical substances applied during or immediately after treatment. This is a genuine mechanism rather than a marketing addition — the channels are transient openings through the epidermal barrier, and the barrier is precisely what normally limits how much of a topical agent reaches the dermis.
It also carries an obvious corollary that is less often stated: anything applied to freshly needled skin has far greater access than it would otherwise have. That makes the choice of what goes on the skin immediately afterwards a clinical decision rather than a cosmetic one, and it is a reason to be cautious about applying active or fragranced products at home in the days following treatment.
What the evidence base actually supports
Reviews of microneedling in human subjects report use across scars, acne, melasma, photodamage, general skin rejuvenation, hyperhidrosis and alopecia, alongside its role in transdermal drug delivery. That breadth is genuine, but it is worth reading carefully: much of the published literature consists of case series and small non-randomised cohorts rather than large randomised trials.
The honest position is that microneedling has a well-characterised mechanism and a broad but unevenly rigorous evidence base. It is a reasonable tool for several indications, and it is not a treatment that requires overstatement to justify its place.
When microneedling is deferred
Active inflammatory acne, active infection in the treatment area, and a history of keloid or hypertrophic scarring all warrant caution or deferral. Treating over active acne means creating channels through inflamed tissue, and where a healing response is already dysregulated, deliberately provoking another one is not neutral.
An assessment that concludes the timing is wrong is a legitimate result. It is more useful than a course of sessions that cannot work while the underlying condition is uncontrolled.
What assessment establishes
Fitzpatrick skin type, the concern being treated, its depth, the regions involved and any active inflammation or infection. Depth and pass count follow from that assessment rather than from a fixed menu.
References
- Tehrani L, Tashjian M, Mayrovitz HN. Physiological Mechanisms and Therapeutic Applications of Microneedling: A Narrative Review. Cureus. 2025;17(3):e80510. PMC11993440
- Jaiswal S, Jawade S. Microneedling in Dermatology: A Comprehensive Review of Applications, Techniques, and Outcomes. Cureus. 2024;16(9):e70033. PMC11499218
- Microneedling: A Means of Collagen Induction Therapy. Journal of Dermatology and Dermatologic Surgery. JDDS
- Evaluation of microneedling depth of penetration in management of atrophic acne scars: a split-face comparative study. PubMed 38159109
If you are unsure whether this suits your skin, an in-person assessment is the way to establish it.
Book My AppointmentFrequently Asked Questions
It depends on the indication. Published guidance cites roughly 1.5 to 2.0 mm for scars and 0.5 to 1.0 mm for ageing skin and wrinkles, within an overall device range of 0.5 to 3.5 mm.
No. Home-care dermarollers use needles under 0.15 mm, intended for topical delivery rather than dermal remodelling. They do not reach the layer where collagen remodelling occurs.
Because it is non-ablative and the epidermis remains largely intact, which limits dyspigmentation compared with ablative techniques such as CO2 laser resurfacing.
Published discussion notes that treating the full dermal depth generally requires several passes at different depths, rather than one pass at maximum depth.
It remodels dermal tissue rather than repositioning descended tissue. Structural laxity at the SMAS layer is addressed by a different modality at a different depth.